117 related articles for article (PubMed ID: 19444461)
1. Five commonly used markers (p53, TTF1, CK7, CK20, and CK34betaE12) are of no use in distinguishing between primary endocervical and endometrial adenocarcinomas in a tissue microarray extension study.
Han CP; Kok LF; Lee MY; Wu TS; Ruan A; Cheng YW; Wang PH; Koo CL; Tyan YS
Arch Gynecol Obstet; 2010 Feb; 281(2):317-23. PubMed ID: 19444461
[TBL] [Abstract][Full Text] [Related]
2. A reappraisal of three-marker (ER/Vim/CEA), four-marker (ER/Vim/CEA/PR), and five-marker (ER/Vim/CEA/PR/p16INK4a) panels in the diagnostic distinction between primary endocervical and endometrial adenocarcinomas in a tissue microarray study.
Han CP; Lee MY; Kok LF; Wu TS; Cheng YW; Wang PH; Yue CH; Tyan YS
Arch Gynecol Obstet; 2010 May; 281(5):845-50. PubMed ID: 19847454
[TBL] [Abstract][Full Text] [Related]
3. Ancillary p16(INK4a) adds no meaningful value to the performance of ER/PR/Vim/CEA panel in distinguishing between primary endocervical and endometrial adenocarcinomas in a tissue microarray study.
Yao CC; Kok LF; Lee MY; Wang PH; Wu TS; Tyan YS; Cheng YW; Kung MF; Han CP
Arch Gynecol Obstet; 2009 Sep; 280(3):405-13. PubMed ID: 19153755
[TBL] [Abstract][Full Text] [Related]
4. True cytokeratin 8/18 immunohistochemistry is of no use in distinguishing between primary endocervical and endometrial adenocarcinomas in a tissue microarray study.
Hsu JD; Yao CC; Lee MY; Kok LF; Wang PH; Tyan YS; Han CP
Int J Gynecol Pathol; 2010 May; 29(3):282-9. PubMed ID: 20407331
[TBL] [Abstract][Full Text] [Related]
5. Adding the p16(INK4a) marker to the traditional 3-marker (ER/Vim/CEA) panel engenders no supplemental benefit in distinguishing between primary endocervical and endometrial adenocarcinomas in a tissue microarray study.
Han CP; Lee MY; Kok LF; Ruan A; Wu TS; Cheng YW; Tyan YS; Lin CY
Int J Gynecol Pathol; 2009 Sep; 28(5):489-96. PubMed ID: 19696622
[TBL] [Abstract][Full Text] [Related]
6. Comparing the scoring mechanisms of p16INK4a immunohistochemistry based on independent nucleic stains and independent cytoplasmic stains in distinguishing between endocervical and endometrial adenocarcinomas in a tissue microarray study.
Kok LF; Lee MY; Tyan YS; Wu TS; Cheng YW; Kung MF; Wang PH; Han CP
Arch Gynecol Obstet; 2010 Feb; 281(2):293-300. PubMed ID: 19418062
[TBL] [Abstract][Full Text] [Related]
7. p16 INK4 and CEA can be mutually exchanged with confidence between both relevant three-marker panels (ER/Vim/CEA and ER/Vim/p16 INK4) in distinguishing primary endometrial adenocarcinomas from endocervical adenocarcinomas in a tissue microarray study.
Han CP; Lee MY; Tyan YS; Kok LF; Yao CC; Wang PH; Hsu JD; Tseng SW
Virchows Arch; 2009 Oct; 455(4):353-61. PubMed ID: 19763614
[TBL] [Abstract][Full Text] [Related]
8. An immunohistochemical study of cervical neuroendocrine carcinomas: Neoplasms that are commonly TTF1 positive and which may express CK20 and P63.
McCluggage WG; Kennedy K; Busam KJ
Am J Surg Pathol; 2010 Apr; 34(4):525-32. PubMed ID: 20182342
[TBL] [Abstract][Full Text] [Related]
9. Progesterone receptor does not improve the performance and test effectiveness of the conventional 3-marker panel, consisting of estrogen receptor, vimentin and carcinoembryonic antigen in distinguishing between primary endocervical and endometrial adenocarcinomas in a tissue microarray extension study.
Liao CL; Lee MY; Tyan YS; Kok LF; Wu TS; Koo CL; Wang PH; Chao KC; Han CP
J Transl Med; 2009 May; 7():37. PubMed ID: 19476621
[TBL] [Abstract][Full Text] [Related]
10. Use of caveolin-1, thyroid transcription factor-1, and cytokeratins 7 and 20 in discriminating between primary and secondary pulmonary adenocarcinoma from breast or colonic origin.
Tsao SC; Su YC; Wang SL; Chai CY
Kaohsiung J Med Sci; 2007 Jul; 23(7):325-31. PubMed ID: 17606426
[TBL] [Abstract][Full Text] [Related]
11. Role of TTF-1, CK20, and CK7 immunohistochemistry for diagnosis of primary and secondary lung adenocarcinoma.
Su YC; Hsu YC; Chai CY
Kaohsiung J Med Sci; 2006 Jan; 22(1):14-9. PubMed ID: 16570563
[TBL] [Abstract][Full Text] [Related]
12. Endocervical adenocarcinomas with prominent endometrial or endomyometrial involvement simulating primary endometrial carcinomas: utility of HPV DNA detection and immunohistochemical expression of p16 and hormone receptors to confirm the cervical origin of the corpus tumor.
Yemelyanova A; Vang R; Seidman JD; Gravitt PE; Ronnett BM
Am J Surg Pathol; 2009 Jun; 33(6):914-24. PubMed ID: 19295407
[TBL] [Abstract][Full Text] [Related]
13. Cytokeratin 7 and cytokeratin 20 expression in colorectal adenocarcinomas.
Bayrak R; Yenidünya S; Haltas H
Pathol Res Pract; 2011 Mar; 207(3):156-60. PubMed ID: 21282015
[TBL] [Abstract][Full Text] [Related]
14. Cytokeratins 7 and 20 in primary and secondary mucinous tumors of the ovary: analysis of coordinate immunohistochemical expression profiles and staining distribution in 179 cases.
Vang R; Gown AM; Barry TS; Wheeler DT; Yemelyanova A; Seidman JD; Ronnett BM
Am J Surg Pathol; 2006 Sep; 30(9):1130-9. PubMed ID: 16931958
[TBL] [Abstract][Full Text] [Related]
15. Distinction between endometrial and endocervical adenocarcinoma: an immunohistochemical study.
Castrillon DH; Lee KR; Nucci MR
Int J Gynecol Pathol; 2002 Jan; 21(1):4-10. PubMed ID: 11781516
[TBL] [Abstract][Full Text] [Related]
16. Distinguishing between primary endocervical and endometrial adenocarcinomas: is a 2-marker (Vim/CEA) panel enough?
Liao CL; Hsu JD; Lee MY; Kok LF; Li YJ; Wang PH; Yao CC; Han CP
Virchows Arch; 2010 Apr; 456(4):377-86. PubMed ID: 20221633
[TBL] [Abstract][Full Text] [Related]
17. Utility of p16 expression for distinction of uterine serous carcinomas from endometrial endometrioid and endocervical adenocarcinomas: immunohistochemical analysis of 201 cases.
Yemelyanova A; Ji H; Shih IeM; Wang TL; Wu LS; Ronnett BM
Am J Surg Pathol; 2009 Oct; 33(10):1504-14. PubMed ID: 19623034
[TBL] [Abstract][Full Text] [Related]
18. Primary seminal vesicle carcinoma: an immunohistochemical analysis of four cases.
Ormsby AH; Haskell R; Jones D; Goldblum JR
Mod Pathol; 2000 Jan; 13(1):46-51. PubMed ID: 10658909
[TBL] [Abstract][Full Text] [Related]
19. Adenocarcinomas metastatic to the liver: the value of cytokeratins 20 and 7 in the search for unknown primary tumors.
Tot T
Cancer; 1999 Jan; 85(1):171-7. PubMed ID: 9921990
[TBL] [Abstract][Full Text] [Related]
20. p16 immunoreactivity may assist in the distinction between endometrial and endocervical adenocarcinoma.
McCluggage WG; Jenkins D
Int J Gynecol Pathol; 2003 Jul; 22(3):231-5. PubMed ID: 12819388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
